Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.630
-0.060 (-3.55%)
At close: Mar 13, 2026, 4:00 PM EDT
1.650
+0.020 (1.23%)
After-hours: Mar 13, 2026, 7:32 PM EDT
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $244.32 million as of March 13, 2026. Its market cap has increased by 96.40% in one year.
Market Cap
244.32M
Enterprise Value
126.56M
1-Year Change
96.40%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $244.32M, a decrease of -39.55%. That is a compound annual growth rate of -4.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 244.30M | 42.37% |
| Dec 31, 2025 | 171.60M | 7.92% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 257.95M |
| Ovid Therapeutics | 256.46M |
| Rezolute | 248.34M |
| Aldeyra Therapeutics | 248.25M |
| Alector | 242.80M |
| Nuvectis Pharma | 239.22M |
| Editas Medicine | 238.81M |
| Tenax Therapeutics | 238.01M |